- Home
- CLDI
as 07-26-2024 4:00pm EST
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 11.7M | IPO Year: | N/A |
| Target Price: | $16.67 | AVG Volume (30 days): | 310.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -6.90 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.41 - $137.90 | Next Earning Date: | 08-19-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Calidi Biotherapeutics Inc. News
CLDI Breaking Stock News: Dive into CLDI Ticker-Specific Updates for Smart Investing
GlobeNewswire
8 days ago
Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform
GlobeNewswire
10 days ago
Calidi Biotherapeutics Announces Appointment of Dr. Mark Gilbert to Medical Advisory Board
Business Wire
21 days ago
Calidi to Effect Reverse Stock Split
Business Wire
a month ago
Calidi Biotherapeutics Announces Appointment of Cancer Immunotherapy Pioneer Dr. George Peoples to Board of Directors
Business Wire
a month ago
Calidi Biotherapeutics to Host Exclusive Live Investor Webinar and Q&A Session on June 13
GuruFocus.com
2 months ago
Catherine Wood's Strategic Acquisition of PagerDuty Inc Shares
Business Wire
2 months ago
ADM Animal Nutrition Expands Recall to Include Additional Lots of Various Feed Products
GuruFocus.com
2 months ago
Insider Sale at Cogent Communications Holdings Inc (CCOI): CFO Thaddeus Weed Sells 2,400 Shares
Compare CLDI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CLDI Calidi Biotherapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.